Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 61, Issue 24, Pages 10996-11020Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.8b00876
Keywords
-
Categories
Funding
- National Science Foundation [CHE1565500]
Ask authors/readers for more resources
Oxygen heterocycles are the second most common type of heterocycles that appear as structural components of U.S. Food and Drug Administration (FDA) approved pharmaceuticals. Analysis of our database of drugs approved through 2017 reveals 311 distinct pharmaceuticals containing at least one oxygen heterocycle. Most prevalent among these are pyranoses, with furanoses, macrolactones, morpholines, and dioxolanes rounding off the top five. The main body of this Perspective is organized according to ring size, commencing with three-and four-membered rings and ending with macrocycles, polymers, and unusual oxygen-containing heterocycles. For each section, all oxygen heterocycle-containing drugs are presented along with a brief discussion about structural and drug application patterns.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available